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The current study examined the effects of the NewGait™ device on walking performance 
in persons with multiple sclerosis (MS). Eight MS patients participated in this study. Pre- 
and post-testing assessed kinematic gait variables (step width, length, and speed), ankle 
range of motion, and rating of perceived exertion (RPE). Participants completed an 8-
week physical therapy (PT) protocol aimed to improve gait and balance, with the 
experimental group wearing the NewGait™ device. Repeated measures mixed ANOVA 
showed no main effects between the gait variables or between groups. Post-hoc paired t-
tests indicated that the NewGait™ device elicited meaningful change in left and right step 
length and speed. The NewGait™ device may be a promising rehabilitation device to help 
induce positive walking performance changes in persons with MS.  
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INTRODUCTION: Multiple sclerosis (MS) is a progressive, degenerative neurological disease 
that affects approximately 2 million people worldwide; symptoms of MS are highly variable 
between individuals, and include sensory, cognitive, and motor impairment (National Multiple 
Sclerosis Society, 2018; Socie & Sosnoff, 2013). LaRocca (2011) found that 70% of people 
with MS, who had difficulty walking, agreed that walking was the most challenging aspect of 
the disease. Walking and gait impairments can have a high negative impact on motor and 
lifestyle activities, with impairments that are associated with a low quality of life and an 
increased risk of falls (Cattaneo et al., 2002).  
Several therapy techniques have been effective in improving gait and mobility. Beer et al. 
(2008) showed that robot-assisted gait training significantly improved distance walked and 
walking velocity versus a conventional walking therapy program when compared to baseline 
values. Colombo et al. (2000) developed a body-weight supported treadmill device that 
utilized a driven gait orthosis and allowed the user to focus on the walking motion . However, 
these therapy techniques are expensive and physically demanding for therapists who have 
the task of controlling and assisting the walking movements. Separate reviews by Kjølhede et 
al. (2012) and Dalgas et al. (2008) have shown that less expensive rehabilitation strategies 
incorporating resistance and endurance training to strengthen or re-train weakened muscles, 
are effective at improving walking gait.  
The NewGait™ device is a modification of a resistance training device called Speedmaker™, 
which was designed to provide resistance to the muscle groups most responsible for speed 
production (Elite Athlete Products, 2017). The NewGait™ device consists of a harness that 
extends over the chest and waist, as well as straps that wrap around the lower thighs and 
below the knees. Elastic resistance bands are strategically placed to offer assistance to 
various joints, typically connecting between the harness and the leg straps and between the 
leg straps and the patient’s shoes. The NewGait™ device is primarily an assistive device 
guiding the wearer into an optimal walking form. User-specific customization can add or 
remove bands to produce the desired assistance. This device has shown anecdotal clinical 
improvements in walking performance for a variety of populations, but requires more rigorous 
controlled research, especially in MS patients. This device may be more cost effective for 
persons with MS to use, in addition, it is more practical than other gait devices as it is light, 
compact, and is easy to carry.  
915
36th Conference of the International Society of Biomechanics in Sports, Auckland, New Zealand, September 10-14, 2018
Published by NMU Commons, 2018
 
 
The purpose of this study was to compare if the addition of the NewGait™ device to traditional 
therapy in comparison to traditional therapy alone would be more effective at improving 
walking technique and walking performance in persons with multiple sclerosis.  
 
METHODS: Eight female participants (height = 164.4 cm ± 5.89; mass = 78 kg ± 24.64) were 
recruited to participate in an 8-week rehabilitation intervention. Approval for this study was 
granted by the Human Subjects Institutional Review Board of Northern Michigan University, 
Marquette, Michigan, USA (IRB# HS17-870). Inclusion criteria required participants to be in a 
stable phase of their MS, have chronic progressive pattern or relapsing-remitting MS with no 
relapse during the past three months, and have an Expanded Disability Status Scale (EDSS) 
score between 5 and 7 (Kurtzke, 1983). Participants were excluded if they had any cardiac 
related risk factor, major orthopedic problems or contractures of the lower limbs, complete 
inability to stand or walk for a longer period than three months, significant medical 
comorbidities, and cognitive or psychiatric problems that could compromise compliance with 
physical therapy (PT). Participants who met all the inclusion criteria completed an informed 
consent.  
Testing took place before and after the 8-week PT intervention. On both the pre- and post-
testing days, participants performed six 10-meter walk trials. Participants had 34 reflective 
markers placed on their left and right ASIS and PSIS, lateral and medial knees, lateral and 
medial ankles, metatarsals (1st and 5th), and calcaneus, with additional 4 marker clusters 
placed mid-thigh and mid-shank. Kinematics were measured using a 10 camera analysis 
system sampling at 250 Hz, digitized and Butterworth filtered at 10 Hz using Cortex Motion 
Analysis software (Motion Analysis Corporation, Santa Rosa, CA, USA). Ten-meter walk time 
was assessed using four timing gates (Witty Wireless Training Timer system, Mahopac, NY, 
USA). For the first three walking trials, participants walked under normal conditions and were 
instructed to “walk as quickly and as safely as you can”. After the three trials, participants 
were fitted with a NewGait™ device for their particular gait abnormality by a licensed PT 
and/or a certified prosthetist. The participants then repeated the three 10-meter walk trials 
wearing the device. For the purpose of this research, data from the control walks (not 
wearing the NewGait™ device) were reported. Rating of perceived exertion (RPE) using 
Borg’s RPE scale of 0-10 was recorded following each set of three walking trials.  
Following pre-testing, participants were matched to another individual with similar gait 
impairments and EDSS score. Participants were then randomly assigned into either the 
control or experimental group based on a coin flip. The experimental group wore the 
NewGait™ device during PT, while the control participants did not. Participants began PT 
within one week of pre-testing. PT sessions occurred twice a week, for 60 minutes each, and 
included gait, balance, functional balance, and mat exercises, as well as neurological tests.  
Kinematic gait variables (step width, step length (SL), speed, and ankle range of motion 
(ROM)) were calculated by creating a conventional gait model using a CODA pelvis created 
in Visual 3D (Version 4.0, C-Motion, Inc., Germantown, MD, USA), and by following standard 
Visual 3D protocol for recognition of gait events (Zeni, Richards, & Higginson, 2008). Range 
of motion of the ankle was calculated using the minimum and maximum angles of the ankle 
joint during the swing and stance phases of the gait cycle. A repeated measured mixed 
ANOVA was used to analyse kinematic variables. Statistical analyses were completed with 
SPSS (version 24). Cohen’s D effect size was calculated to assess change across time for 
each group. Additional paired t-tests were run to investigate pre-post comparisons within 
groups when large effect sizes were present. 
 
RESULTS: Repeated measures mixed ANOVA revealed no main effects between the gait 
variables or between the control and experimental conditions (Table 1). In addition, there was 
no interaction between the variables (p > 0.05). Post-hoc paired t-tests run based on large 
effect size indicated that the experimental group showed meaningful change in left and right 
step length and speed (Table 2). The control group showed meaningful change in left step 
length and left ankle ROM during the swing phase (Table 2).  
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Table 1: Mean ± SD, p-values and effect sizes for gait variables and rating of perceived 
exertion (RPE) pre- and post-intervention for the control and experimental groups. 
 
Control Group (n = 4) Experimental Group (n = 4) p-value 
Pre Post Pre Post Time Time*Group 
Step Width (m) 0.14 0.15 0.16 0.14 0.67 0.22 
Left SL (m) 0.46 0.54 0.52 0.69 0.02 0.33 
Right SL (m) 0.53 0.57 0.54 0.69 0.03 0.19 
Speed (m/sec) 0.90 0.98 0.99 1.36 0.03 0.13 
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 Left Ankle 
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31.73 31.62 27.39 26.42 
0.73 0.78 
 
Table 2: Difference, p-value, and effect size for left and right SL, speed, and ankle ROM 
during swing for the control and experimental groups.  
Variable 
Control Group (n = 4) Experimental Group (n = 4) 
Diff p d Diff p d 
Left SL (m) -0.082 0.060 -0.947 -0.158 0.098 -0.884 
Right SL (m) - - - -0.149 0.117 -0.777 
Speed (m/sec) - - - -0.368 0.103 -0.717 
SWING  
Left Ankle ROM (°) 
3.439 0.246 0.896 - - - 
 
DISCUSSION: The main finding was that an 8-week PT intervention that focused on gait and 
balance was effective at improving walking technique and performance, as seen by the 
differences in left step length and left ankle ROM during the swing phase in the control group. 
However, there is evidence to suggest that the addition of the NewGait™ assistive device to 
PT may also be effective at further improving walking gait and performance, as shown by the 
differences in left and right step length, and speed in the experimental group.  
These findings are in agreement with Beer et al. (2008) and Schwartz et al. (2012) who both 
used robot-assisted gait training and reported improvements in walking distance and velocity. 
Although the NewGait™ device differs greatly from that technique in terms of cost and 
versatility; the current findings also agreed with Kjølhede et al. (2012), Dalgas et al. (2008), 
and Gutierrez (2005) who note that less expensive rehabilitation techniques are also effective 
at improving walking gait. Gutierrez et al. (2005), found that two months of resistance training 
could elicit a significant increase in step length and foot angle.  
No longitudinal research has been conducted on the effectiveness of the NewGait™ device, 
but past research using robot-assisted gait training indicates that any improvements seen in 
gait function at the conclusion of the study were not detectable at 6 months post (Beer et al., 
2008; Schwartz et al., 2012). However, an advantage of the NewGait™ device is that due to 
its low cost and portability, the device could be used outside a PT setting, meaning that 
individuals could continue using it long-term.  
A limitation of the current study was the lack of power from a small sample size. However, it 
should be noted that the current study uses a subsample of participants from an ongoing 
study; future publications will include the entire sample. Another limitation may be the length 
of the PT intervention. If the intervention was longer or included more sessions, participants 
may have shown greater improvements in their walking performance. Day et al. (2002) 
indicate that there may be a positive correlation between results of balance therapy and 
number of sessions, with more sessions equating to more optimal results. Future research 
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should use a longer PT intervention and study the longitudinal effects of the NewGait™ 
device.  
 
CONCLUSION: The purpose of this study was to compare if the addition of the NewGait™ 
device to traditional therapy in comparison to traditional therapy alone would be more 
effective at improving walking technique and walking performance in persons with multiple 
sclerosis. Primary results showed no main effect between gait variables or between groups. 
Post-hoc t-tests indicated that the traditional therapy group experienced meaningful change 
in unilateral step length and ankle ROM however, the NewGait™ device demonstrated 
meaningful change in bi-lateral step length and walking speed. The NewGait™ is cost-
effective and mobile, which makes it easy to use for physical therapists and patients. The 
ability to customize the device to each individual may also be an attractive quality for physical 
therapists who see a variety of patients with a multitude of impairments.  
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